Microsoft Corp. signed an agreement to put to rest accusations that it used a litmus test to deny software discounts to conservative faith-based groups.
Novo Nordisk Tries to Snatch a Weight-Loss Biotech From Pfizer. There Are Political Risks. Denmark’s Novo offers $56.50 a share in cash for Metsera, plus potentially a further $21.25 a share based on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback